193 related articles for article (PubMed ID: 26969892)
1. Deregulated methionine adenosyltransferase α1, c-Myc, and Maf proteins together promote cholangiocarcinoma growth in mice and humans(‡).
Yang H; Liu T; Wang J; Li TW; Fan W; Peng H; Krishnan A; Gores GJ; Mato JM; Lu SC
Hepatology; 2016 Aug; 64(2):439-55. PubMed ID: 26969892
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
[TBL] [Abstract][Full Text] [Related]
3. Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells.
Fan W; Yang H; Liu T; Wang J; Li TW; Mavila N; Tang Y; Yang J; Peng H; Tu J; Annamalai A; Noureddin M; Krishnan A; Gores GJ; Martínez-Chantar ML; Mato JM; Lu SC
Hepatology; 2017 Apr; 65(4):1249-1266. PubMed ID: 27981602
[TBL] [Abstract][Full Text] [Related]
4. Induction of avian musculoaponeurotic fibrosarcoma proteins by toxic bile acid inhibits expression of glutathione synthetic enzymes and contributes to cholestatic liver injury in mice.
Yang H; Ko K; Xia M; Li TW; Oh P; Li J; Lu SC
Hepatology; 2010 Apr; 51(4):1291-301. PubMed ID: 20146260
[TBL] [Abstract][Full Text] [Related]
5. A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression.
Yang H; Li TW; Peng J; Tang X; Ko KS; Xia M; Aller MA
Gastroenterology; 2011 Jul; 141(1):378-88, 388.e1-4. PubMed ID: 21440549
[TBL] [Abstract][Full Text] [Related]
6. Switch from Mnt-Max to Myc-Max induces p53 and cyclin D1 expression and apoptosis during cholestasis in mouse and human hepatocytes.
Yang H; Li TW; Ko KS; Xia M; Lu SC
Hepatology; 2009 Mar; 49(3):860-70. PubMed ID: 19086036
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal Regulation Between Forkhead Box M1/NF-κB and Methionine Adenosyltransferase 1A Drives Liver Cancer.
Li Y; Lu L; Tu J; Zhang J; Xiong T; Fan W; Wang J; Li M; Chen Y; Steggerda J; Peng H; Chen Y; Li TWH; Zhou ZG; Mato JM; Seki E; Liu T; Yang H; Lu SC
Hepatology; 2020 Nov; 72(5):1682-1700. PubMed ID: 32080887
[TBL] [Abstract][Full Text] [Related]
8. Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis.
Carino A; Biagioli M; Marchianò S; Fiorucci C; Bordoni M; Roselli R; Di Giorgio C; Baldoni M; Ricci P; Monti MC; Morretta E; Zampella A; Distrutti E; Fiorucci S
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Sep; 1865(9):158733. PubMed ID: 32371093
[TBL] [Abstract][Full Text] [Related]
9. Deregulated 14-3-3ζ and methionine adenosyltransferase α1 interplay promotes liver cancer tumorigenesis in mice and humans.
Lu L; Zhang J; Fan W; Li Y; Wang J; Li TWH; Barbier-Torres L; Mato JM; Liu T; Seki E; Matsuda M; Tomasi ML; Bhowmick NA; Yang H; Lu SC
Oncogene; 2021 Sep; 40(39):5866-5879. PubMed ID: 34349244
[TBL] [Abstract][Full Text] [Related]
10. Hepatic prohibitin 1 and methionine adenosyltransferase α1 defend against primary and secondary liver cancer metastasis.
Fan W; Cao D; Yang B; Wang J; Li X; Kitka D; Li TWH; You S; Shiao S; Gangi A; Posadas E; Di Vizio D; Tomasi ML; Seki E; Mato JM; Yang H; Lu SC
J Hepatol; 2024 Mar; 80(3):443-453. PubMed ID: 38086446
[TBL] [Abstract][Full Text] [Related]
11. Myc, Max, and Mnt: molecular mechanisms of enhancement of cholangiocarcinogenesis by cholestasis.
Nakamura I; Roberts LR
Gastroenterology; 2011 Jul; 141(1):32-4. PubMed ID: 21620848
[No Abstract] [Full Text] [Related]
12. Methionine Adenosyltransferase α1 Is Targeted to the Mitochondrial Matrix and Interacts with Cytochrome P450 2E1 to Lower Its Expression.
Murray B; Peng H; Barbier-Torres L; Robinson AE; Li TWH; Fan W; Tomasi ML; Gottlieb RA; Van Eyk J; Lu Z; Martínez-Chantar ML; Liangpunsakul S; Skill NJ; Mato JM; Lu SC
Hepatology; 2019 Dec; 70(6):2018-2034. PubMed ID: 31077594
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
14. c-Maf negatively regulates ARE-mediated detoxifying enzyme genes expression and anti-oxidant induction.
Dhakshinamoorthy S; Jaiswal AK
Oncogene; 2002 Aug; 21(34):5301-12. PubMed ID: 12149651
[TBL] [Abstract][Full Text] [Related]
15. Activation of a novel c-Myc-miR27-prohibitin 1 circuitry in cholestatic liver injury inhibits glutathione synthesis in mice.
Yang H; Li TW; Zhou Y; Peng H; Liu T; Zandi E; Martínez-Chantar ML; Mato JM; Lu SC
Antioxid Redox Signal; 2015 Jan; 22(3):259-74. PubMed ID: 25226451
[TBL] [Abstract][Full Text] [Related]
16. Depletion of mitochondrial methionine adenosyltransferase α1 triggers mitochondrial dysfunction in alcohol-associated liver disease.
Barbier-Torres L; Murray B; Yang JW; Wang J; Matsuda M; Robinson A; Binek A; Fan W; Fernández-Ramos D; Lopitz-Otsoa F; Luque-Urbano M; Millet O; Mavila N; Peng H; Ramani K; Gottlieb R; Sun Z; Liangpunsakul S; Seki E; Van Eyk JE; Mato JM; Lu SC
Nat Commun; 2022 Jan; 13(1):557. PubMed ID: 35091576
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis distinguishing the DNA binding profile of Nrf2-Maf heterodimer from that of Maf homodimer.
Kimura M; Yamamoto T; Zhang J; Itoh K; Kyo M; Kamiya T; Aburatani H; Katsuoka F; Kurokawa H; Tanaka T; Motohashi H; Yamamoto M
J Biol Chem; 2007 Nov; 282(46):33681-33690. PubMed ID: 17875642
[TBL] [Abstract][Full Text] [Related]
18. Molecular determinants for small Maf protein control of platelet production.
Motohashi H; Fujita R; Takayama M; Inoue A; Katsuoka F; Bresnick EH; Yamamoto M
Mol Cell Biol; 2011 Jan; 31(1):151-62. PubMed ID: 20974807
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA EPIC1 promotes cholangiocarcinoma cell growth.
Li Y; Cai Q; Li W; Feng F; Yang L
Biochem Biophys Res Commun; 2018 Oct; 504(4):654-659. PubMed ID: 30205958
[TBL] [Abstract][Full Text] [Related]
20. Decrease of miR-622 expression promoted the proliferation, migration and invasion of cholangiocarcinoma cells by targeting regulation of c-Myc.
Wu YF; Li ZR; Cheng ZQ; Yin XM; Wu JS
Biomed Pharmacother; 2017 Dec; 96():7-13. PubMed ID: 28961507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
